Diagnos Laboratorium Utama Tbk. vs MAP Boga Adiperkasa Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while MAP Boga Adiperkasa Tbk. trades at Rp1,110 (market cap 2.41T, 200.1K 24h volume). The key difference: MAP Boga Adiperkasa Tbk. is far larger — about 7.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 200.1K). Which is the better fit depends on your goals.
| DGNS | MAPB | |
|---|---|---|
Market Cap | 310.75B | 2.41T |
Volume | 963.6K | 200.1K |
Lot | 9.64K | 2K |
Turnover | 217.67M | 222.11M |
Average Price | 225.89 | 1,110 |
Value | 217.67M | 222.11M |
Indicative Equilibrium Price | 226 | 1,110 |
Indicative Equilibrium Volume | 1K | 2 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Map Boga Adiperkasa (formerly PT. Creasi Aksesoris Indonesia) (the Company) was established based on notarial deed No. 01 dated January 7, 2013 of Lilis Sugianto, S.H., notary in Jakarta.
Read more on MAPB →